deltatrials
No Longer Available EXPANDED_ACCESS NCT03740516

Expanded Access for CC-10004

Sponsor: Amgen

Conditions Bechet's Disease
Interventions CC-10004
Updated 6 times since 2018 Last updated: Apr 27, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03740516, this observational or N/A phase trial focuses on Bechet's Disease and remains ongoing. Sponsored by Amgen, it has been updated 6 times since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshotAvailable~Jan 2019 – ~May 2020 · 16 months · monthly snapshotNo Longer Available~May 2020 – ~Jan 2021 · 8 months · monthly snapshotNo Longer Available~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotNo Longer Available~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotNo Longer Available~Sep 2024 – present · 22 months · monthly snapshotNo Longer Available

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    No Longer Available

  2. Jul 2024 — Sep 2024 [monthly]

    No Longer Available

  3. Jan 2021 — Jul 2024 [monthly]

    No Longer Available

  4. May 2020 — Jan 2021 [monthly]

    No Longer Available

  5. Jan 2019 — May 2020 [monthly]

    No Longer Available

    Status: Available → No Longer Available

▶ Show 1 earlier version

  1. Dec 2018 — Jan 2019 [monthly]

    Available

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Amgen
Data source: Amgen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations